Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET
Company Participants
Zack Kubow - IR, Pure Communications
Leiv Lea - CFO
Richard Miller - President & CEO
Conference Call Participants
Biren Amin - Jefferies
Michael Vincent Morabito - Crédit Suisse
Robert Driscoll - Wedbush Securities
Operator
Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the Corvus Pharmaceuticals First Quarter 2019 Business Update and Financial Results Conference Call. Today's conference is being recorded. [Operator Instructions] It is now my pleasure to turn the call over to Zack Kubow of Pure Communications. Please go ahead, sir.
Zack Kubow
Thank you, operator, and good afternoon, everyone. Thanks for joining us for the Corvus Pharmaceutical's First Quarter 2019 Business Update and Financial Results Conference Call. On the call to discuss the results and business highlights for the first quarter 2019 are Richard Miller, Chief Executive Officer; Leiv Lea, Chief Financial Officer; and Mehrdad Mobasher, Chief Medical Officer, who is traveling and phoning in remotely. The executive team will open the call with some prepared remarks followed by a question-and-answer period.
I would like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Forward-looking statements are based on estimates and assumptions as of today and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by those statements including the risks and uncertainties described in Corvus' quarterly report on Form 10-Q filed with the SEC today and other filings the company makes with the SEC from time to time. The company undertakes no obligation to publicly update or revise any forward-looking statements except as required by law.
With that, I'd like to turn the call over to Leiv
- Read more current CRVS analysis and news
- View all earnings call transcripts